COMMUNIQUÉS West-GlobeNewswire

IBA - Transparency Notification
17/06/2019
Louvain-la-Neuve, Belgium, June 17, 2019, 17.35 Summary of the notification IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to [...]
IBA - Publication relative à une notification de transparence
17/06/2019
Louvain-la-Neuve, Belgique, 17 juin 2019, 17.35 Résumé de la notification IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce devoir [...]
Sanofi: information concerning the total number of voting rights and shares, May 2019
17/06/2019
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi : informations relatives au nombre total de droits de vote et d’actions, mai 2019
17/06/2019
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
BioPorto A/S to Increase its Share Capital through a Cash Issue, Private Placement
17/06/2019
June 17, 2019 Announcement no. 8 BioPorto A/S to Increase its Share Capital through a Cash Issue, Private Placement NOT FOR RELEASE , PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, [...]
Ossur Hf : Transactions in relation to share buyback program
17/06/2019
Announcement no. 37/2019 17 June 2019 Transactions in relation to share buyback program On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019. The purpose of the share [...]
Boehringer Ingelheim and OSE Immunotherapeutics Announce Dosing Of the First Patient in a Phase 1 Trial of SIRPα Antagonist Monoclonal Antibody, BI 765063, in Patients with Advanced Solid Tumors
17/06/2019
First-in-class checkpoint inhibitor BI 765063 licensed to and being developed under a collaboration agreement between Boehringer Ingelheim and OSE Immunotherapeutics Clinical Trial Authorization and dosing of the first [...]
Federal Court of Appeal Upholds I-MED Pharma’s Patent Win Against TearLab
17/06/2019
MONTREAL, June 17, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the Canadian Federal Court of Appeal confirmed that TearLab’s [...]
Polydex Pharmaceuticals Issues First Quarter Financial Results
17/06/2019
Net Profit up for the Quarter TORONTO, June 17, 2019 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “company”) is pleased to report financial results for the first quarter of fiscal 2020, [...]
Naboso™ Technology and TrueForm Runner Launch the First and Only Proprioceptive Treadmill for Rehabilitation and Performance
17/06/2019
Innovative textured material on a self-powered treadmill aids in balance, stability and post-training injuries NEW YORK, June 17, 2019 (GLOBE NEWSWIRE) -- A patent-pending textured material developed by Naboso™ [...]
Government Can’t Be Trusted with Your Medical Care, States President of the Association of American Physicians and Surgeons (AAPS)
17/06/2019
TUCSON, Ariz., June 17, 2019 (GLOBE NEWSWIRE) -- As the pressure mounts to enact Medicare for All, the president of the Association of American Physicians and Surgeons (AAPS) reviews the checkered history of the U.S. [...]
Precipio CEO Provides Update Letter To Shareholders
17/06/2019
NEW HAVEN, Conn., June 17, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), provides an update to its shareholders. Dear Investors: We are all aware of the recent pricing pressure [...]
Notification on convocation of joint stock company “GRINDEKS” Extraordinary General Meeting of shareholders
17/06/2019
The Management Board of joint stock company “Grindeks” (registration number: 40003034935, legal address: 53 Krustpils street, Riga, Latvia, LV-1057) according the shareholder’s “Liplat Holding” Ltd., who represents 72, [...]
Indus Holdings, Inc. Announces Voluntary Extended Lock-Up Agreements for Insiders
17/06/2019
SALINAS, Calif., June 17, 2019 (GLOBE NEWSWIRE) -- Indus Holdings, Inc. ("Indus") (CSE:INDS), a leading, vertically-integrated cannabis company, today announced that the executive officers and directors of the company [...]
Merit Medical Acquires Brightwater Medical, Inc.
17/06/2019
SOUTH JORDAN, Utah, June 17, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]
Parallax Health Sciences Deemed Prevailing Party and Anticipates Impending Judgment to Collect Recovery of Prior Attorney Fees and Expenses Incurred in Relation to Melamed Rescission Matter
17/06/2019
SANTA MONICA, CA, June 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company, today announced [...]
Theratechnologies Confirms Decision to Pursue Development of Tesamorelin for NASH in HIV
17/06/2019
MONTREAL, June 17, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that it will pursue the development of tesamorelin for the treatment of Non-alcoholic steatohepatitis (“ [...]
Theratechnologies confirme sa décision d’aller de l’avant avec le développement de la tésamoréline pour le traitement de la stéatohépatite non alcoolique (NASH) en VIH
17/06/2019
MONTRÉAL, 17 juin 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) a annoncé aujourd’hui qu’elle ira de l’avant avec le développement de la tésamoréline pour le traitement de la [...]
Groundbreaking Pre-Patient Trial from Ocutrx Vision Technologies Yields Exciting Results for Patients with AMD
17/06/2019
New Oculenz Headset Enhances Functional Vision for Patients with Severe Age-Related Macular Degeneration IRVINE, Calif., June 17, 2019 (GLOBE NEWSWIRE) -- Ocutrx Vision Technologies, LLC , an advanced research and [...]

Pages